Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Co-Diagnostics Inc’s stock clocked out at $0.26, down -1.65% from its previous closing price of $0.27. In other words, the price has decreased by -$1.65 from its previous closing price. On the day, 0.58 million shares were traded. CODX stock price reached its highest trading level at $0.2928 during the session, while it also had its lowest trading level at $0.2625.
Ratios:
To gain a deeper understanding of CODX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.23 and its Current Ratio is at 4.43. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 29, 2021, Sidoti started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 8849531 and an Enterprise Value of -10698234. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.53 while its Price-to-Book (P/B) ratio in mrq is 0.18. Its current Enterprise Value per Revenue stands at -3.059 whereas that against EBITDA is 0.289.
Stock Price History:
The Beta on a monthly basis for CODX is 0.59, which has changed by -0.79126984 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $2.23, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is -14.55%, while the 200-Day Moving Average is calculated to be -63.39%.
Shares Statistics:
It appears that CODX traded 387.65K shares on average per day over the past three months and 440570 shares per day over the past ten days. A total of 33.57M shares are outstanding, with a floating share count of 30.68M. Insiders hold about 9.00% of the company’s shares, while institutions hold 17.44% stake in the company. Shares short for CODX as of 1749772800 were 282095 with a Short Ratio of 0.73, compared to 1747267200 on 166099. Therefore, it implies a Short% of Shares Outstanding of 282095 and a Short% of Float of 0.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating for Co-Diagnostics Inc (CODX) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.68 and -$0.68 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.34, with 1.0 analysts recommending between -$0.34 and -$0.34.
Revenue Estimates
In the current quarter, 1 analysts expect revenue to total $300k. It ranges from a high estimate of $300k to a low estimate of $300k. As of the current estimate, Co-Diagnostics Inc’s year-ago sales were $2.66MFor the next quarter, 1 analysts are estimating revenue of $300k. There is a high estimate of $300k for the next quarter, whereas the lowest estimate is $300k.
A total of 1 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $950k, while the lowest revenue estimate was $950k, resulting in an average revenue estimate of $950k. In the same quarter a year ago, actual revenue was $3.92M
